Amarin Corp Plc\uk SEC filings AMRN
Amarin Corp Plc\uk has 1,003 filings in SEC EDGAR's recent list, going back to Feb 3, 2012. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 27, 2026 | — |
| 4 | Insider transaction | Aug 3, 2026 | Aug 1, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 15, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | Apr 29, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 18, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 18, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 18, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 18, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 18, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 18, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 18, 2026 |
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 10, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 25, 2026 |
| 10-K | Annual report | Mar 2, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 1, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 31, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 8, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 3 | Initial insider ownership | Oct 31, 2025 | Oct 17, 2025 |
| 10-Q | Quarterly report | Oct 29, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2025 | Oct 17, 2025 |
| 4 | Insider transaction | Aug 4, 2025 | Aug 1, 2025 |
| EFFECT | Filing | Jul 31, 2025 | — |
| 10-Q | Quarterly report | Jul 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| F-6 | Form f-6 | Jul 23, 2025 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Jul 3, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Regulation FD disclosure
|
Jun 24, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Apr 29, 2025 | Apr 29, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 4 | Insider transaction | Apr 22, 2025 | Apr 18, 2025 |
| 3 | Initial insider ownership | Apr 11, 2025 | Apr 3, 2025 |
| ARS | Annual report to shareholders | Apr 10, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 13, 2025 |
| 8-K |
Current report
Change to shareholder rights, Regulation FD disclosure
|
Apr 9, 2025 | Apr 9, 2025 |
| 4 | Insider transaction | Apr 9, 2025 | Mar 1, 2025 |
| PRER14A | Filing | Apr 7, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 7, 2025 | Apr 4, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2025 | Mar 28, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 25, 2025 | — |
| F-6 POS | Filing | Mar 12, 2025 | — |
| 10-K | Annual report | Mar 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Change to shareholder rights, Regulation FD disclosure
|
Mar 12, 2025 | Mar 12, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 30, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 22, 2024 | Nov 22, 2024 |
| 3 | Initial insider ownership | Oct 31, 2024 | Oct 23, 2024 |
| 10-Q | Quarterly report | Oct 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Aug 5, 2024 | Aug 2, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 31, 2023 |
| 4 | Insider transaction | Aug 1, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2024 | Jul 31, 2024 |
| 10-Q | Quarterly report | Jul 31, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2024 | Jul 25, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 4, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Listing notice
|
May 29, 2024 | May 24, 2024 |
| S-8 | Employee stock plan registration | May 1, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 1, 2024 | May 1, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Apr 22, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 19, 2024 | Apr 18, 2024 |
| 8-K |
Current report
Other events
|
Apr 3, 2024 | Apr 3, 2024 |
| ARS | Annual report to shareholders | Mar 4, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Mar 4, 2024 | Apr 18, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 29, 2024 | Feb 29, 2024 |
| PRE 14A | Preliminary proxy statement | Feb 12, 2024 | Feb 12, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 9, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 26, 2024 | Jan 25, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 2, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Jan 2, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Dec 14, 2023 | Dec 12, 2023 |
| 144 | Notice of proposed sale | Dec 12, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 8, 2023 | — |
| 4 | Insider transaction | Dec 5, 2023 | Dec 1, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 5, 2023 | — |
| 3 | Initial insider ownership | Nov 21, 2023 | Nov 15, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 3, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2023 | Nov 1, 2023 |
| 10-Q | Quarterly report | Nov 1, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 31, 2023 | Oct 31, 2023 |
| UPLOAD | Letter from the SEC | Oct 26, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 5, 2023 | — |
| 4 | Insider transaction | Aug 16, 2023 | Aug 16, 2023 |
| EFFECT | Filing | Aug 15, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2023 | — |
| 4 | Insider transaction | Aug 2, 2023 | Aug 1, 2023 |
| 4 | Insider transaction | Aug 2, 2023 | Jul 31, 2023 |
| 4 | Insider transaction | Aug 2, 2023 | Jul 31, 2023 |
| S-8 | Employee stock plan registration | Aug 2, 2023 | — |
| S-3 | Shelf registration | Aug 2, 2023 | — |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 3 | Initial insider ownership | Jul 28, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 25, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 21, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 4 | Insider transaction | Jul 21, 2023 | Jul 19, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2023 | Jul 18, 2023 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Jul 18, 2023 | Jul 18, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 20, 2023 |
| DEFA14A | Additional proxy material | Jun 26, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 23, 2023 | Jun 21, 2023 |
| 4 | Insider transaction | Jun 22, 2023 | Jun 20, 2023 |
| DEFA14A | Additional proxy material | Jun 8, 2023 | — |
| ARS | Annual report to shareholders | May 26, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | May 26, 2023 | — |
| PRE 14A | Preliminary proxy statement | May 9, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| 10-Q | Quarterly report | May 3, 2023 | Mar 31, 2023 |
| 10-K/A | Amended annual report | May 1, 2023 | Dec 31, 2022 |
| 3 | Initial insider ownership | Apr 27, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 17, 2023 | Apr 17, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 31, 2023 | Mar 27, 2023 |
| 3 | Initial insider ownership | Mar 10, 2023 | Feb 28, 2023 |
| 3 | Initial insider ownership | Mar 10, 2023 | Feb 28, 2023 |
| 3 | Initial insider ownership | Mar 10, 2023 | Feb 28, 2023 |
| 3 | Initial insider ownership | Mar 10, 2023 | Feb 28, 2023 |
| 3 | Initial insider ownership | Mar 10, 2023 | Feb 28, 2023 |
| 3 | Initial insider ownership | Mar 10, 2023 | Feb 28, 2023 |
| 3 | Initial insider ownership | Mar 10, 2023 | Feb 28, 2023 |
| 4 | Insider transaction | Mar 8, 2023 | Feb 28, 2023 |
| 4 | Insider transaction | Mar 8, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Mar 2, 2023 | Feb 28, 2023 |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2023 | Mar 1, 2023 |
| DFAN14A | Filing | Feb 28, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 28, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AMRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Dublin 2
- SEC filer status
- Accelerated filer
- SEC CIK
- 897448
- Former names
- AMARIN CORP PLC\UK (until Oct 28, 2026); AMARIN PHARMACEUTICALS PLC (until Jul 13, 2000); ETHICAL HOLDINGS PLC (until Jan 28, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.